TRAF4 overexpression is a common characteristic of human carcinomas

Tumor necrosis factor receptor (TNFR) associated factor 4 (TRAF4) was initially identified as a gene amplified and overexpressed in breast carcinomas. Our aim was to evaluate whether TRAF4 protein overexpression exists in other cancer types. Immunohistochemistry analysis of tumor samples from 623 patients with 20 different tumor types showed that TRAF4 was overexpressed in 268 tumors (43%), including 82 of 137 lung adenocarcinomas (60%). Interestingly, 32 primary tumors and their matching metastases exhibited mostly similar TRAF4 expression pattern. TRAF4 protein overexpression was limited to cancer cells and the subcellular localization was consistently cytoplasmic in a large majority of cases. To investigate changes in TRAF4 gene copy number, 125 cases from six different types of carcinomas were also analysed by fluorescence in situ hybridization. Out of the 28 cases (22%) showing an increased TRAF4 gene copy number, 23 (82%) were overexpressing the protein. Thus, TRAF4 gene amplification is one of the mechanisms responsible for TRAF4 protein overexpression in human cancers. Considering that TRAF4 is located at 17q11.2 in a region of amplification devoid of known oncogenes and is commonly overexpressed in cancer, our data support an oncogenic role for TRAF4.

[1]  A. Dierich,et al.  Impaired neural tube closure, axial skeleton malformations, and tracheal ring disruption in TRAF4-deficient mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  F. Nwariaku,et al.  Involvement of TRAF4 in Oxidative Activation of c-Jun N-terminal Kinase* , 2002, The Journal of Biological Chemistry.

[3]  Annuska M Glas,et al.  Gene expression profiles of primary breast tumors maintained in distant metastases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J W Gray,et al.  Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  W. El-Deiry,et al.  Identification and Characterization of the Cytoplasmic Protein TRAF4 as a p53-regulated Proapoptotic Gene* , 2003, Journal of Biological Chemistry.

[6]  P. Brown,et al.  Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. Johnson,et al.  MEKK4 Is an Effector of the Embryonic TRAF4 for JNK Activation* , 2005, Journal of Biological Chemistry.

[8]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.

[9]  P. Basset,et al.  Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17. , 1995, Genomics.

[10]  J. Testa,et al.  Chromosomal imbalances in human lung cancer , 2002, Oncogene.

[11]  P. Basset,et al.  Presence of a New Conserved Domain in CART1, a Novel Member of the Tumor Necrosis Factor Receptor-associated Protein Family, Which Is Expressed in Breast Carcinoma (*) , 1995, The Journal of Biological Chemistry.

[12]  F. Hirsch,et al.  Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas , 2002, British Journal of Cancer.

[13]  P. Scheurich,et al.  Intracellular localization and transcriptional regulation of tumor necrosis factor (TNF) receptor-associated factor 4 (TRAF4). , 2002, European journal of biochemistry.

[14]  C. Coban,et al.  TRAF4 acts as a silencer in TLR‐mediated signaling through the association with TRAF6 and TRIF , 2005, European Journal of Immunology.

[15]  G. Sarosi,et al.  Subcellular targeting of oxidants during endothelial cell migration , 2005, The Journal of cell biology.

[16]  J. Boylan,et al.  Nek8, a NIMA family kinase member, is overexpressed in primary human breast tumors. , 2004, Gene.

[17]  R. Redon,et al.  Genomic and Expression Profiling of Chromosome 17 in Breast Cancer Reveals Complex Patterns of Alterations and Novel Candidate Genes , 2004, Cancer Research.

[18]  R. Arch,et al.  TRAF4 functions as an intermediate of GITR-induced NF-κB activation , 2004, Cellular and Molecular Life Sciences CMLS.

[19]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[20]  B. Aggarwal.  Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.

[21]  M. Christie,et al.  Acute Tumor Necrosis Factor Alpha Signaling via NADPH Oxidase in Microvascular Endothelial Cells: Role of p47phox Phosphorylation and Binding to TRAF4 , 2005, Molecular and Cellular Biology.

[22]  C. Hauser,et al.  TRAF Family Proteins Interact with the Common Neurotrophin Receptor and Modulate Apoptosis Induction* , 1999, The Journal of Biological Chemistry.

[23]  High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression. , 2004 .

[24]  Christian A. Rees,et al.  Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.